Integra LifeSciences Holdings Corporation (IART)
USD 19.49
(-2.84%)
USD 19.49
(-2.84%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.19 Billion USD | 5.21% |
| 2022 | 2.08 Billion USD | -0.58% |
| 2021 | 2.09 Billion USD | -0.13% |
| 2020 | 2.1 Billion USD | 11.33% |
| 2019 | 1.88 Billion USD | 8.91% |
| 2018 | 1.73 Billion USD | -22.98% |
| 2017 | 2.24 Billion USD | 132.26% |
| 2016 | 968.28 Million USD | -5.37% |
| 2015 | 1.02 Billion USD | 17.04% |
| 2014 | 874.3 Million USD | 66.2% |
| 2013 | 526.04 Million USD | -18.55% |
| 2012 | 645.82 Million USD | -0.87% |
| 2011 | 651.47 Million USD | 25.93% |
| 2010 | 517.34 Million USD | 4.47% |
| 2009 | 495.21 Million USD | -27.62% |
| 2008 | 684.22 Million USD | 22.71% |
| 2007 | 557.58 Million USD | 75.64% |
| 2006 | 317.45 Million USD | 100.14% |
| 2005 | 158.61 Million USD | 6.53% |
| 2004 | 148.89 Million USD | 3.4% |
| 2003 | 143.99 Million USD | 431.92% |
| 2002 | 27.07 Million USD | 15.04% |
| 2001 | 23.53 Million USD | -28.11% |
| 2000 | 32.73 Million USD | 15.66% |
| 1999 | 28.3 Million USD | 757.58% |
| 1998 | 3.3 Million USD | 26.92% |
| 1997 | 2.6 Million USD | 13.04% |
| 1996 | 2.3 Million USD | 15.0% |
| 1995 | 2 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 2.48 Billion USD | 13.04% |
| 2024 Q2 | 2.54 Billion USD | 2.42% |
| 2024 Q3 | 2.54 Billion USD | 0.15% |
| 2023 Q2 | 2.09 Billion USD | 1.3% |
| 2023 Q4 | 2.19 Billion USD | 1.57% |
| 2023 Q1 | 2.06 Billion USD | -0.86% |
| 2023 FY | 2.19 Billion USD | 5.21% |
| 2023 Q3 | 2.16 Billion USD | 3.14% |
| 2022 FY | 2.08 Billion USD | -0.58% |
| 2022 Q2 | 2.09 Billion USD | 1.71% |
| 2022 Q1 | 2.05 Billion USD | -1.94% |
| 2022 Q3 | 2.08 Billion USD | -0.45% |
| 2022 Q4 | 2.08 Billion USD | 0.13% |
| 2021 Q3 | 2.14 Billion USD | 0.23% |
| 2021 Q2 | 2.13 Billion USD | -3.36% |
| 2021 FY | 2.09 Billion USD | -0.13% |
| 2021 Q1 | 2.21 Billion USD | 5.33% |
| 2021 Q4 | 2.09 Billion USD | -2.11% |
| 2020 Q2 | 2.04 Billion USD | -3.0% |
| 2020 Q3 | -475.59 Million USD | -123.28% |
| 2020 Q4 | 2.1 Billion USD | 541.61% |
| 2020 FY | 2.1 Billion USD | 11.33% |
| 2020 Q1 | 2.1 Billion USD | 11.62% |
| 2019 Q1 | 1.8 Billion USD | 4.42% |
| 2019 Q4 | 1.88 Billion USD | -3.83% |
| 2019 FY | 1.88 Billion USD | 8.91% |
| 2019 Q3 | 1.96 Billion USD | 4.93% |
| 2019 Q2 | 1.86 Billion USD | 3.36% |
| 2018 Q3 | 1.43 Billion USD | -22.32% |
| 2018 FY | 1.73 Billion USD | -22.98% |
| 2018 Q4 | 1.73 Billion USD | 20.93% |
| 2018 Q2 | 1.84 Billion USD | 0.65% |
| 2018 Q1 | 1.83 Billion USD | -18.54% |
| 2017 Q1 | 1.19 Billion USD | 23.57% |
| 2017 FY | 2.24 Billion USD | 132.26% |
| 2017 Q4 | 2.24 Billion USD | 49.42% |
| 2017 Q3 | 1.5 Billion USD | 24.74% |
| 2017 Q2 | 1.2 Billion USD | 0.84% |
| 2016 Q1 | 1.05 Billion USD | 2.99% |
| 2016 Q2 | 1.01 Billion USD | -3.27% |
| 2016 FY | 968.28 Million USD | -5.37% |
| 2016 Q3 | 1 Billion USD | -1.51% |
| 2016 Q4 | 968.28 Million USD | -3.56% |
| 2015 Q1 | 862.7 Million USD | -1.33% |
| 2015 FY | 1.02 Billion USD | 17.04% |
| 2015 Q3 | 1.09 Billion USD | 18.5% |
| 2015 Q2 | 926.17 Million USD | 7.36% |
| 2015 Q4 | 1.02 Billion USD | -6.77% |
| 2014 Q2 | 873.79 Million USD | -0.33% |
| 2014 Q3 | 859.75 Million USD | -1.61% |
| 2014 Q4 | 874.3 Million USD | 1.69% |
| 2014 Q1 | 876.72 Million USD | 66.66% |
| 2014 FY | 874.3 Million USD | 66.2% |
| 2013 Q2 | 670.91 Million USD | 3.76% |
| 2013 FY | 526.04 Million USD | -18.55% |
| 2013 Q4 | 526.04 Million USD | -23.16% |
| 2013 Q3 | 684.59 Million USD | 2.04% |
| 2013 Q1 | 646.6 Million USD | 0.12% |
| 2012 Q2 | 654.6 Million USD | 0.72% |
| 2012 Q3 | 658.8 Million USD | 0.64% |
| 2012 Q4 | 645.82 Million USD | -1.97% |
| 2012 FY | 645.82 Million USD | -0.87% |
| 2012 Q1 | 649.91 Million USD | -0.24% |
| 2011 Q1 | 479.44 Million USD | -7.33% |
| 2011 Q2 | 635.03 Million USD | 32.45% |
| 2011 Q3 | 673.14 Million USD | 6.0% |
| 2011 FY | 651.47 Million USD | 25.93% |
| 2011 Q4 | 651.47 Million USD | -3.22% |
| 2010 Q4 | 517.34 Million USD | 5.91% |
| 2010 FY | 517.34 Million USD | 4.47% |
| 2010 Q3 | 488.47 Million USD | 1.47% |
| 2010 Q2 | 481.41 Million USD | 0.28% |
| 2010 Q1 | 480.07 Million USD | -3.06% |
| 2009 Q3 | 542.81 Million USD | -0.14% |
| 2009 Q2 | 543.59 Million USD | -12.49% |
| 2009 FY | 495.21 Million USD | -27.62% |
| 2009 Q4 | 495.21 Million USD | -8.77% |
| 2009 Q1 | 621.14 Million USD | -9.22% |
| 2008 Q3 | 639.15 Million USD | 18.72% |
| 2008 Q1 | 683.77 Million USD | 22.63% |
| 2008 FY | 684.22 Million USD | 22.71% |
| 2008 Q2 | 538.36 Million USD | -21.27% |
| 2008 Q4 | 684.22 Million USD | 7.05% |
| 2007 Q2 | 552.97 Million USD | 74.15% |
| 2007 FY | 557.58 Million USD | 75.64% |
| 2007 Q4 | 557.58 Million USD | -0.37% |
| 2007 Q3 | 559.68 Million USD | 1.21% |
| 2007 Q1 | 317.52 Million USD | 0.02% |
| 2006 FY | 317.45 Million USD | 100.14% |
| 2006 Q3 | 298.97 Million USD | 17.63% |
| 2006 Q2 | 254.17 Million USD | 39.21% |
| 2006 Q1 | 182.58 Million USD | 15.11% |
| 2006 Q4 | 317.45 Million USD | 6.18% |
| 2005 Q1 | 156.06 Million USD | 4.82% |
| 2005 FY | 158.61 Million USD | 6.53% |
| 2005 Q4 | 158.61 Million USD | 0.21% |
| 2005 Q3 | 158.27 Million USD | 0.82% |
| 2005 Q2 | 156.99 Million USD | 0.59% |
| 2004 Q1 | 143.12 Million USD | -0.61% |
| 2004 FY | 148.89 Million USD | 3.4% |
| 2004 Q4 | 148.89 Million USD | 0.91% |
| 2004 Q3 | 147.55 Million USD | 0.29% |
| 2004 Q2 | 147.12 Million USD | 2.8% |
| 2003 Q2 | 154.44 Million USD | 14.11% |
| 2003 FY | 143.99 Million USD | 431.92% |
| 2003 Q4 | 143.99 Million USD | -7.38% |
| 2003 Q3 | 155.47 Million USD | 0.67% |
| 2003 Q1 | 135.34 Million USD | 399.96% |
| 2002 Q2 | 19.24 Million USD | 5.12% |
| 2002 Q3 | 24.96 Million USD | 29.75% |
| 2002 Q4 | 27.07 Million USD | 8.43% |
| 2002 FY | 27.07 Million USD | 15.04% |
| 2002 Q1 | 18.3 Million USD | -22.21% |
| 2001 FY | 23.53 Million USD | -28.11% |
| 2001 Q1 | 34.2 Million USD | 4.5% |
| 2001 Q2 | 31.67 Million USD | -7.41% |
| 2001 Q4 | 23.53 Million USD | -1.91% |
| 2001 Q3 | 23.99 Million USD | -24.25% |
| 2000 Q3 | 34.63 Million USD | 5.48% |
| 2000 Q1 | 30.21 Million USD | 6.75% |
| 2000 FY | 32.73 Million USD | 15.66% |
| 2000 Q4 | 32.73 Million USD | -5.49% |
| 2000 Q2 | 32.83 Million USD | 8.68% |
| 1999 Q1 | 25 Million USD | 657.58% |
| 1999 Q2 | 28.6 Million USD | 14.4% |
| 1999 FY | 28.3 Million USD | 757.58% |
| 1999 Q3 | 27.4 Million USD | -4.2% |
| 1999 Q4 | 28.3 Million USD | 3.28% |
| 1998 Q4 | 3.3 Million USD | -25.0% |
| 1998 Q1 | 3.7 Million USD | 42.31% |
| 1998 Q2 | 4.1 Million USD | 10.81% |
| 1998 Q3 | 4.4 Million USD | 7.32% |
| 1998 FY | 3.3 Million USD | 26.92% |
| 1997 Q3 | 3 Million USD | 30.43% |
| 1997 FY | 2.6 Million USD | 13.04% |
| 1997 Q1 | 2.2 Million USD | -4.35% |
| 1997 Q2 | 2.3 Million USD | 4.55% |
| 1997 Q4 | 2.6 Million USD | -13.33% |
| 1996 FY | 2.3 Million USD | 15.0% |
| 1996 Q3 | 2.3 Million USD | 9.52% |
| 1996 Q2 | 2.1 Million USD | 16.67% |
| 1996 Q1 | 1.8 Million USD | -10.0% |
| 1996 Q4 | 2.3 Million USD | 0.0% |
| 1995 FY | 2 Million USD | 0.0% |
| 1995 Q3 | 2.6 Million USD | 0.0% |
| 1995 Q4 | 2 Million USD | -23.08% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | -4180.844% |
| BrainsWay Ltd. | 15.31 Million USD | -14227.439% |
| Cerus Corporation | 144.3 Million USD | -1420.473% |
| Envoy Medical, Inc. | 9.4 Million USD | -23236.567% |
| electroCore, Inc. | 8.94 Million USD | -24428.832% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -40972.707% |
| IceCure Medical Ltd | 4.24 Million USD | -51562.444% |
| Inogen, Inc. | 121.38 Million USD | -1707.602% |
| OrthoPediatrics Corp. | 72.56 Million USD | -2923.806% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -7317.275% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -68854.849% |
| MaxCyte, Inc. | 36.1 Million USD | -5976.672% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -118634.354% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -515818.651% |
| Orthofix Medical Inc. | 326.58 Million USD | -571.832% |
| PAVmed Inc | 57.13 Million USD | -3740.076% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -8516.832% |
| RxSight, Inc. | 22.18 Million USD | -9788.697% |
| Sight Sciences, Inc. | 46.43 Million USD | -4625.006% |
| SI-BONE, Inc. | 61.05 Million USD | -3493.946% |
| TELA Bio, Inc. | 59.16 Million USD | -3608.324% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | -1825.176% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -21162.758% |
| Acutus Medical, Inc. | 54.83 Million USD | -3900.992% |
| Talis Biomedical Corporation | 29.22 Million USD | -7407.884% |
| Spectral AI, Inc. | 12.4 Million USD | -17592.96% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -9384.326% |
| CVRx, Inc. | 39.28 Million USD | -5485.52% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -18248.3% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -90218.363% |
| Bioventus Inc. | 589.79 Million USD | -272.013% |
| Venus Concept Inc. | 107.1 Million USD | -1948.592% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | -4146.954% |
| LivaNova PLC | 1.15 Billion USD | -90.471% |
| 908 Devices Inc. | 37.49 Million USD | -5752.505% |
| Alphatec Holdings, Inc. | 703.48 Million USD | -211.889% |
| Nemaura Medical Inc. | 26.37 Million USD | -8218.111% |
| NeuroPace, Inc. | 86.99 Million USD | -2422.046% |
| LENSAR, Inc. | 22.4 Million USD | -9691.173% |
| Apyx Medical Corporation | 52.31 Million USD | -4093.784% |
| Cutera, Inc. | 518.12 Million USD | -323.473% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -7381.26% |
| BioSig Technologies, Inc. | 4.68 Million USD | -46732.529% |
| Anika Therapeutics, Inc. | 58.36 Million USD | -3659.152% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -10110.834% |
| Axonics, Inc. | 82.35 Million USD | -2564.073% |
| Outset Medical, Inc. | 190.91 Million USD | -1049.257% |
| IRIDEX Corporation | 24.91 Million USD | -8706.711% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | -1669.938% |
| IRadimed Corporation | 20.73 Million USD | -10481.168% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -130969.534% |
| INVO Bioscience, Inc. | 19.99 Million USD | -10873.284% |
| Telesis Bio, Inc. | 40.87 Million USD | -5268.101% |
| Viemed Healthcare, Inc. | 40.79 Million USD | -5278.994% |
| Varex Imaging Corporation | 668.6 Million USD | -228.164% |
| Quipt Home Medical Corp. | 136.29 Million USD | -1509.843% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -61325.084% |
| Pulmonx Corporation | 60.63 Million USD | -3518.484% |
| Dynatronics Corporation | 11.78 Million USD | -18525.489% |
| Modular Medical, Inc. | 2.27 Million USD | -96471.479% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -53888.78% |
| Semler Scientific, Inc. | 6.27 Million USD | -34893.684% |
| InMode Ltd. | 75.91 Million USD | -2790.249% |
| Bruker Corporation | 2.83 Billion USD | 22.65% |
| Cytosorbents Corporation | 29.98 Million USD | -7217.224% |
| DexCom, Inc. | 4.19 Billion USD | 47.708% |
| Align Technology, Inc. | 2.45 Billion USD | 10.568% |
| Viveve Medical, Inc. | 10.84 Million USD | -20127.75% |
| ZimVie Inc. | 795.85 Million USD | -175.692% |
| Movano Inc. | 5.97 Million USD | -36639.853% |
| Cytek Biosciences, Inc. | 104.6 Million USD | -1997.514% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -515818.651% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -18248.3% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | -243.351% |
| Profound Medical Corp. | 12.66 Million USD | -17222.971% |
| Insulet Corporation | 1.85 Billion USD | -18.249% |
| enVVeno Medical Corporation | 2.43 Million USD | -90006.94% |
| Surmodics, Inc. | 65.82 Million USD | -3233.339% |
| iCAD, Inc. | 8 Million USD | -27322.876% |
| Nuwellis, Inc. | 6.78 Million USD | -32261.416% |
| Biotricity, Inc. | 35.91 Million USD | -6008.402% |
| iRhythm Technologies, Inc. | 223.04 Million USD | -883.696% |
| Aethlon Medical, Inc. | 2.47 Million USD | -88384.423% |
| InspireMD, Inc. | 8.14 Million USD | -26847.977% |
| PAVmed Inc. | 57.13 Million USD | -3740.076% |
| BIOLASE, Inc. | 35.34 Million USD | -6107.152% |
| Beyond Air, Inc. | 29.77 Million USD | -7268.947% |
| FONAR Corporation | 57.45 Million USD | -3718.65% |
| AxoGen, Inc. | 101.16 Million USD | -2068.901% |
| Vivani Medical, Inc. | 25.03 Million USD | -8663.796% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | -2399.093% |
| Inari Medical, Inc. | 209.32 Million USD | -948.181% |
| UFP Technologies, Inc. | 118.04 Million USD | -1758.701% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -17189.351% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -100279.356% |
| Tenon Medical, Inc. | 5.56 Million USD | -39312.682% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -123233.558% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -12342.382% |
| AdaptHealth Corp. | 3.15 Billion USD | 30.416% |
| Sintx Technologies, Inc. | 6.59 Million USD | -33179.296% |
| NanoVibronix, Inc. | 2.68 Million USD | -81586.672% |
| Quanterix Corporation | 78.08 Million USD | -2709.928% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -61325.084% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -44815.128% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | -110.021% |
| TransMedics Group, Inc. | 568.84 Million USD | -285.712% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -13052.524% |
| NeuroMetrix, Inc. | 1.33 Million USD | -164483.64% |
| Hyperfine, Inc. | 9.8 Million USD | -22288.816% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | -776.779% |
| Biomerica, Inc. | 2.66 Million USD | -82292.189% |
| Bone Biologics Corporation | 831.4 Thousand USD | -263804.104% |
| AVITA Medical, Inc. | 19.86 Million USD | -10944.85% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -111068.004% |
| Silk Road Medical, Inc | 114.15 Million USD | -1821.989% |